- Alternative Therapies
- Blood, Heart and Circulation
- Bones and Muscles
- Brain and Nerves
- Cancers
- Child health
- Cosmetic Surgery
- Digestive System
- Disorders and Conditions
- Drugs Approvals and Trials
- Environmental Health
- Ear, Nose and Throat
- Eyes and Vision
- Female Reproductive
- Genetics and Birth Defects
- Geriatrics and Aging
- Immune System
- Infections
- Kidneys and Urinary System
- Life style and Fitness
- Lungs and Breathing
- Male Reproductive
- Medical Breakthroughs
- Mental Health and Behavior
- Metabolic Problems
- Oral and Dental Health
- Pregnancy and Childbirth
- Public Health and Safety
- Skin, Hair and Nails
- Substance Abuse
- Surgery and Rehabilitation
OHSU tests new fish oil/lipoic acid combination as Alzheimer’s treatment
Pioneering clinical trial examines whether fish oil and lipoic acid combination slows cognitive and functional decline associated with Alzheimer’s disease
Portland, Ore. - Oregon Health & Science University researchers are expanding a study that found a combination of dietary supplements slows the cognitive and functional decline associated with Alzheimer’s disease. The results may help enable people with mild to moderate Alzheimer’s to live independently.
The new clinical trial will involve 100 participants in Portland, Bend, Medford and Klamath Falls who will receive either a combination of lipoic acid and fish oil or a placebo. An earlier pilot study demonstrated that the combination of these dietary supplements slows the mental decline of Alzheimer’s patients.
In addition, the OHSU research team will examine the effects of fish oil and lipoic acid on other factors – including diabetes, high blood pressure and cardiovascular disease – which are associated with an increased risk of Alzheimer’s. “There is some evidence that lipoic acid improves insulin metabolism – or insulin resistance – in diabetics,” said Lynne Shinto, N.D., M.P.H., assistant professor of neurology in the OHSU School of Medicine and lead investigator on the project.
The study is the first to consider the possible effects of insulin resistance on the progression of Alzheimer’s disease. Insulin is key to the body’s ability to extract a sugar called glucose, the body’s main source of energy, from food. That’s potentially important to treating Alzheimer’s because the human brain uses large amounts of glucose.
The new clinical trial also will examine whether the fish oil and lipoic acid combination reduces inflammation, which can lead to brain atrophy.
The National Institutes of Health and the National Institute on Aging funded the study.
About OHSU
Oregon Health & Science University is the state’s only health and research university, and Oregon’s only academic health center. OHSU is Portland's largest employer and the fourth largest in Oregon (excluding government). OHSU's size contributes to its ability to provide many services and community support activities not found anywhere else in the state. It serves patients from every corner of the state, and is a conduit for learning for more than 3,400 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to every county in the state.
# # #



del.icio.us
Digg